News Breaks |
|
|
| January 2, 2013 |
| 07:58 EDT |  | AFFY | Affymax weakness a buying opportunity, says RW Baird at RW Baird
Baird expects Affymax shares to recover over the next few months following another bullish survey from Omontys users which indicated robust demand, and improved perceptions and preference for the drug. Shares are Outperform rated with a $30 price target. |
|
|
News For AFFY From The Last 14 Days Check below for free stories on AFFY the last two weeks. |
|
|
| May 14, 2013 |
| 18:15 EDT |  | AFFY | Affymax CEO to step down
 Subscribe for More Information |
|
| 07:18 EDT |  | AFFY | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. |
|
|
|
|
|
